Categories
I-CARE Early Covid (187)
I-CARE Flu and RSV (36)
I-PREVENT (153)
I-RECOVER Long Covid (111)
I-RECOVER Post-Vaccine (320)
MATH+ (198)
Tags
ACE2 protein (10)
acute respiratory distress syndrome (14)
Alopecia (7)
Anti-inflammatory (9)
Antidepressants (9)
Ascorbic Acid (12)
autoantibodies (10)
autophagy (24)
Calcifediol (6)
Cancer (9)
Corticosteroids (9)
COVID-19 (270)
COVID-19 Vaccines (8)
Curcumin (8)
Cytokines (12)
Depression (10)
Famotidine (14)
flavonoids (5)
Glucocorticoids (7)
Hydroxychloroquine (12)
Hyperbaric Oxygen Therapy (9)
Inflammation (14)
ivermectin (47)
long COVID (21)
Mast Cells (8)
Melatonin (20)
Methylprednisolone (7)
molnupiravir (5)
N-Acetylcysteine (6)
Non-Invasive Brain Stimulation (8)
Omicron (7)
Oxytocin (8)
Pneumonia (8)
quercetin (15)
SARS-CoV-2 (72)
SARS-CoV-2 mRNA Vaccines (7)
Sepsis (18)
spermidine (11)
Spike Protein (10)
Thiamine (7)
Thrombosis (9)
Tinnitus (12)
Vitamin C (28)
Vitamin D (10)
Zinc (12)
Authors: Titos E, Rius B, Gonzalez-Periz A, Lopez-Vicario C, Arroyo V, Claria J PMID: 22013115 DOI: 10.4049/jimmunol.1100225 Abstract We recently demonstrated that ω-3-polyunsaturated fatty acids ameliorate obesity-induced adipose tissue inflammation and insulin resistance. In this study, we report novel mechanisms underlying ω-3-polyunsaturated fatty acid actions on adipose tissue, adipocytes, and stromal vascular cells (SVC). [...]
Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-RECOVER Long Covid
Tags: Docosahexaenoic Acid, Resolvin D1
